Human Phenotype
Ontology
|
Grandparent Node: Mortality/Aging (HP:0040006) | Parent Node: Age of death (HP:0011420) | ..Starting node ..Death in adolescence (HP:0011421)
|
Term ID: |
11421 |
Name: |
Death in adolescence |
Synonym: |
Death in adolescence |
Definition: |
Death during adolescence, the period between childhood and adulthood (roughly between the ages of 10 and 19 years). |
Comments: |
|
Reference: |
HP:0011421 |
Genes and Diseases: | | Child Nodes: | Sister Nodes: | ..Death in childhood (HP:0003819)
| ..Death in early adulthood (HP:0100613)
| ..Death in infancy (HP:0001522)
| ..Neonatal death (HP:0003811)
| ..Stillbirth (HP:0003826)
| ..Sudden death (HP:0001699)
| Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: | HPO disease - gene - phenotype less frequent non-typical associations: | HP:0011421 | HP:0011421 | Death in adolescence | 0 | ACTN2 CL E G H | 88 | 164 | OMIM:612158 | Cardiomyopathy, dilated, 1aa, with or without left ventricular noncompaction | | | | 307 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | COX8A CL E G H | 1351 | 2294 | OMIM:619059 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN15 | | | | 1 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | DSP CL E G H | 1832 | 3052 | OMIM:605676 | Cardiomyopathy, dilated, with woolly hair and keratoderma | | | | 747 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | ERCC4 CL E G H | 2072 | 3436 | OMIM:610965 | XFE progeroid syndrome | | | | 158 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | EXOC8 CL E G H | 149371 | 24659 | OMIM:619076 | NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND BRAIN ATROPHY; NEDMISB | | | | 1 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | FGA CL E G H | 2243 | 3661 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 47 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | FGB CL E G H | 2244 | 3662 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 62 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | FGG CL E G H | 2266 | 3694 | OMIM:202400 | Afibrinogenemia, congenitalhypofibrinogenemia, congenital, included | | | | 34 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | GFAP CL E G H | 2670 | 4235 | OMIM:203450 | Alexander disease | | | | 188 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | IL6ST CL E G H | 3572 | 6021 | OMIM:619751 | STUVE-WIEDEMANN SYNDROME 2; STWS2 | | | | | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | MADD CL E G H | 8567 | 6766 | OMIM:619004 | DEEAH SYNDROME; DEEAH | | | | 5 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | MDFIC CL E G H | 29969 | 28870 | OMIM:620014 | | | | | | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | MFSD2A CL E G H | 84879 | 25897 | OMIM:616486 | Microcephaly 15, primary, autosomal recessive | | | | 5 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | OAS1 CL E G H | 4938 | 8086 | OMIM:618042 | Pulmonary alveolar proteinosis with hypogammaglobulinemia | | | | 2 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | PET100 CL E G H | 100131801 | 40038 | OMIM:619055 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN12 | | | | 6 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | PSMB8 CL E G H | 5696 | 9545 | OMIM:256040 | Proteasome-associated autoinflammatory syndrome 1 and digenic forms | | | | 20 | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | SATB1 CL E G H | 6304 | 10541 | OMIM:619229 | KOHLSCHUTTER-TONZ SYNDROME-LIKE; KTZSL | | | | | | | HP:0011421 | HP:0011421 | Death in adolescence | 0 | TPI1 CL E G H | 7167 | 12009 | OMIM:615512 | Triosephosphate isomerase deficiency | | | | 28 | | |
Genes (18) :ACTN2 COX8A DSP ERCC4 EXOC8 FGA FGB FGG GFAP IL6ST MADD MDFIC MFSD2A OAS1 PET100 PSMB8 SATB1 TPI1
Diseases (16) :OMIM:612158 OMIM:619059 OMIM:605676 OMIM:610965 OMIM:619076 OMIM:202400 OMIM:203450 OMIM:619751 OMIM:619004 OMIM:620014 OMIM:616486 OMIM:618042 OMIM:619055 OMIM:256040 OMIM:619229 OMIM:615512 |
Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.
|
|
|